Lackawanna County in Pennsylvania has unleashed a barrage of lawsuits aimed squarely at the drug manufacturers it says have claimed 231 lives in the community since 2014. “Lackawanna County’s commitment to fight the war against drug companies who fueled (the) opioid crisis begins today,” declared County Commissioner Patrick O’ Malley. “The line has been drawn. It’s Lackawanna County versus the pharmaceutical companies.”
The ...
continue reading...
Endo Pharmaceuticals has officially withdrawn Opana ER from the market at the FDA’s request. The extended release opioid medication recently became the subject of an inquiry by the agency because of the specific way it was being abused.
Opana ER was designed to slowly and steadily medicate a patient as an extended release medication. However, when crushed, snorted, or injected, an abuser can get the full dose ...
continue reading...A new study published in the journal Surgery has found that patients recovering from hernia procedures may require far fewer opioids to manage their pain than they are often prescribed. Some data indicates that patients are frequently given up to 30 pills after such procedures, the majority of which are unnecessary and could lead to them becoming addicted to opioids.
The study, helmed by Dr. Peter Masiakos of ...
continue reading...
A series of three successive studies recently published in the journal of Obstetrics & Gynecology suggest that women are drastically over-prescribed dangerous opioids after C-sections. The studies build off each other to provide a complete picture of how women’s pain is less carefully regarded throughout the medical process than that of men.
In one of the studies, 720 C-section patients were followed after giving birth from six ...
continue reading...According to a report published on Reuters, a new government study has found that more than one-third of adults in the US — nearly 100 million people — were prescribed an opioid in 2015. The statistic is staggering, and provides insight into how the opioid crisis is ruining lives across the country.
Results of the study consisted of data from more than 50,000 participants obtained through face-to-face ...
continue reading...The FDA has begun the process of removing a powerful opioid from the market over concerns of the potential for abuse. Endo Pharmaceuticals was recently informed by the agency that it would like to see Opana ER pulled from the nation’s shelves.
Citing concerns over the “public health consequences of abuse,” the agency is giving Endo Pharmaceuticals the opportunity to voluntarily remove Opana ER on its ...
continue reading...
